Discover the top gene editing stocks to watch. Learn about this groundbreaking field and the companies leading advancements in genetic science.

This new technology could one day significantly expand the market for gene-editing biotechs.

New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...

It has also aggressively invested in gene editing, including its 2025 acquisition of cardiovascular disease gene-editing ...

Learn how gene editing is transforming sickle cell disease treatment and why expanding access to younger children matters.

One has FDA approval and revenue; the other is pre-commercial but debt-free. Both face distinct risks that could reshape your ...

The program, called THRIVE, will back seven different teams pursuing various groups of conditions affecting different organ ...

An independent arbitration panel ruled that developing Prime Medicine’s experimental drug for Alpha-1 Antitrypsin Deficiency ...

"Traditional gene-editing technologies work best with single mutations and are expensive to optimize, so gene therapies tend to focus on the mutations that are the most common," Buffington said. "But ...

Gene editing is a group of technologies that enable scientists to precisely alter an organism's DNA. These technologies allow for the addition, removal, or alteration of genetic material at specific ...

An arbitration panel ruled Prime didn’t breach a deal with Beam by developing a rare disease treatment. Elsewhere, European ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free ...